Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Celiac Disease Clinical Trials

A listing of Celiac Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (41) clinical trials

Celiac disease is an inherited, life-long digestive disease affecting children and adults. When people with celiac disease eat certain foods, there is a reaction that damages their small intestine and can interfere with the ability of their intestine to take in nutrients from food. This reaction occurs when they eat ...

Phase N/A

A research study is evaluating an investigational medication for celiac disease.

Phase N/A

ActivMed is seeking adults with Celiac Disease. Celiac Disease is an autoimmune disorder triggered by the consumption of a protein called gluten, which is found in wheat, barley, and rye. Celiac is hereditary and affects more than 3 million Americans causing symptoms like abdomen pain, diarrhea, and bloating.

Phase N/A

Crohn's Disease Endoscopic REmission Definition in an Objective Way

The CDEIS (Crohn's disease endoscopic index of severity) and its derivative, SES-CD (single endoscopic score for Crohn's disease) were constructed to evaluate the endoscopic severity of Crohn's disease (CD). The current therapeutic goal in CD is endoscopic remission, which is thought to be predictive of a favourable evolution of the ...

Phase N/A

Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease

Following a gluten-free diet is difficult. Eating small amounts of gluten may be common. Gluten may cause a wide range of symptoms, or no symptoms at all. Thus, there is not always a 'feedback loop' to alert to accidental gluten exposure. Nevertheless, these "silent" gluten exposures may interfere with recovery ...

Phase N/A

Study of the Safety Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

This study is a 2-part, multicenter study. In Part A, eligible subjects will be enrolled into escalating dose cohorts (n = 2/cohort for 2 dose levels followed by n = 3/cohort for 5 dose levels). TIMP-GLIA will be administered as a single intravenous (IV) infusion on Day 1. A staggered ...

Phase

Is the Endoscopic Remission Evaluation Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline Predictive of Sustained Clinical Remission Using a 2-year Follow up

The CREDO 2 study follows CREDO 1 study, which aims to construct an objective evaluation of endoscopic remission in Crohn's Disease (CD). In addition to reproducibility and validation, the predictive value of this remission evaluation needs to be tested in different settings to valorise its usefulness in clinical practice and ...

Phase N/A

Clinical Trial to Evaluate the Endoscopic Ultrasound Guided Celiac Plexus Block for Treatment of Pain in Chronic Pancreatitis

Inclusion criteria include: age>18 yrs, ability for informed consent, chronic daily pancreatic-type abdominal pain. Exclusion criteria include: pregnancy, malignancy, recent acute pancreatitis (within 2 months), elevated INR (>1.5) or low platelet count (<75 cells/mm3), allergy to eggs or "caine" anesthetics.

Phase N/A

Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]

A cross sectional design incorporating subjects with active celiac disease and healed celiac disease (based on clinically-obtained biopsies); and healthy individuals.

Phase N/A

Transradial Selective Catheterization of the Celiac Artery in Obese Patients

RATIONALE A significant proportion of patients referred to IUCPQ-UL catheterization laboratory are overweight (body mass index >25 kg/m). Ongoing research and early clinical experience suggest that embolization of the left gastric artery could drastically reduce ghrelin levels and be associated with significant weight loss. In obese patients, catheterization using femoral ...

Phase N/A